ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : -7 مورد

Allometric dosing of miltefosine for treatment of visceral leishmaniasis in children <12 years

Allometric dosing of miltefosine for treatment of visceral leishmaniasis in children <12 years
  Total daily allometric miltefosine dose (mg) for patient of indicated height*
60 cm 70 cm 80 cm 90 cm 100 cm 110 cm 120 cm 130 cm 140 cm 150 cm 175 cm 200 cm
Males
9 kg 30 40 40 40 40              
12 kg 40 40 40 50 50 50            
15 kg   40 50 50 60 60 60          
20 kg     50 60 60 70 70 70        
25 kg       60 70 70 80 80 80      
30 kg         80 80 90 90 90 100    
35 kg         80 90 90 100 100 100 110  
40 kg         80 90 100 100 110 110 120 130
45 kg         90 90 100 110 110 120 130 130
50 kg         90 100 100 110 120 120 130 140
55 kg         90 100 110 120 120 130 140 150
60 kg         90 100 110 120 130 130 150 150
65 kg         100 110 110 120 130 140 150 150
75 kg         100 110 120 130 140 140 150 150
85 kg         100 110 120 130 140 150 150 150
Females
9 kg 30 30 30 30 30              
12 kg 30 30 40 40 40 40            
15 kg   40 40 40 50 50 50          
20 kg     50 50 50 60 60 60        
25 kg       60 60 60 70 70 70      
30 kg       60 60 70 70 80 80 80    
35 kg       60 70 70 80 80 80 90 90  
40 kg       70 70 80 80 90 90 90 100 110
45 kg       70 80 80 90 90 100 100 110 110
50 kg       70 80 80 90 100 100 100 110 120
55 kg       70 80 90 90 100 100 110 120 130
60 kg       70 80 90 100 100 110 110 120 130
65 kg       80 80 90 100 110 110 120 130 140
75 kg       80 90 100 100 110 120 120 140 150
85 kg       80 90 100 110 120 120 130 150 150

* The total daily dose was calculated with equation 6 and rounded to the nearest 10 mg (smallest available capsule). To reduce the risk of gastrointestinal side effects upon intake, daily doses are best divided into 3 and given with 8 hour intervals between doses.

¶ A dose of 150 mg is considered to be the maximal tolerable dose that can be administered on a daily basis to a patient.
From: Dorlo TP, Huitema AD, Beijnen JH, de Vries PJ. Optimal dosing of miltefosine in children and adults with visceral leishmaniasis. Antimicrob Agents Chemother 2012; 56:3864-72. doi: 10.1128/AAC.00292-12. Copyright © 2012 American Society for Microbiology. Reproduced with permission from American Society for Microbiology; permission conveyed through Copyright Clearance Center, Inc.
Graphic 121724 Version 7.0